⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Bandhan Healthcare Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | IDFC MF | HDFC MF |
| Category | Equity - Sectoral Fund - Pharma & Health Care | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹10.99 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | BSE Health Care - TRI | BSE Health Care - TRI |
| Fund Manager | Viraj Kulkarni | Nikhil Mathur |
| Inception | 28 Nov 2025 | 04 Oct 2023 |
| Returns | ||
| 1Y | — | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 9.15% | 29.15% |
| Risk | ||
| 15.05 | 14.07 | |
| 0.61 | 0.59 | |
| 0.66 | 1.59 | |
| 22.63 | 21.67 | |
| 1.37 | 3.48 | |
| -7.27% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.31% | 1.03% |
| Exit Load | 0.50% on or before 30D, Nil after 30D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹1,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
IDFC MF59%
HDFC MF59%
41.2%Only 41.2% of holdings by weight are common between IDFC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingIDFC MFHDFC MF
Sun Pharmaceutical Industries Ltd.9.74%8.28%
Divi's Laboratories Ltd.4.27%9.39%
Cipla Ltd.6.18%4.15%
Apollo Hospitals Enterprise Ltd.5.75%3.69%
Max Healthcare Institute Ltd.5.27%3.61%
Lupin Ltd.4.35%3.55%
Torrent Pharmaceuticals Ltd.3.23%3.65%
Shilpa Medicare Ltd.4.17%3.23%
Dr. Reddy's Laboratories Ltd.3.78%3.19%
Glenmark Pharmaceuticals Ltd.2.14%2.09%
Global Health Ltd.1.88%2.72%
Category context: Equity vs Equity. Open the full Screener →